Clal Biotechnology Industries Ltd. announced earnings results for the first quarter ended March 31, 2021. For the first quarter, the company announced total revenue was ILS 45.575 million compared to ILS 39.919 million a year ago. Net loss was ILS 2.626 million compared to ILS 2.787 million a year ago. Basic loss per share from continuing operations was ILS 0.02 compared to ILS 0.02 a year ago.